Ultra Clean (NASDAQ:UCTT – Get Rating) had its target price lowered by Needham & Company LLC from $39.00 to $35.00 in a research note published on Thursday, The Fly reports. UCTT has been the subject of several other reports. TheStreet raised shares of Ultra Clean from a c rating to a b- rating in a […]
Needham & Company LLC restated their buy rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Get Rating) in a report released on Friday, Benzinga reports. Needham & Company LLC currently has a $5.00 price target on the stock. Mereo BioPharma Group Stock Performance Shares of MREO opened at $1.00 on Friday. Mereo BioPharma Group […]
Needham & Company LLC reissued their buy rating on shares of Geron (NASDAQ:GERN – Get Rating) in a research note published on Friday, Benzinga reports. Needham & Company LLC currently has a $4.00 price target on the biopharmaceutical company’s stock. Other equities research analysts have also issued reports about the company. Wedbush restated an outperform […]
Needham & Company LLC reiterated their buy rating on shares of Lucid Diagnostics (NASDAQ:LUCD – Get Rating) in a research report released on Friday morning, Benzinga reports. The firm currently has a $2.60 target price on the stock. Lucid Diagnostics Stock Down 1.9 % LUCD opened at $1.53 on Friday. The stock has a market […]
Mereo BioPharma Group (NASDAQ:MREO – Get Rating)‘s stock had its “buy” rating reiterated by equities researchers at Needham & Company LLC in a research note issued to investors on Friday, Benzinga reports. They presently have a $5.00 price target on the stock. Needham & Company LLC’s price target indicates a potential upside of 405.10% from […]